Keskin, S. Et Al. 2011. The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. 2011 ASCO Annual Meeting , (United States Of America), 10539.

Keskin, S., Eralp, Y., Yılmaz, E. Z., YÖRÜKER, E. E., İĞCİ, A., MÜSLÜMANOĞLU, M. E., ... Yılmaz, S.(2011). The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer . 2011 ASCO Annual Meeting (pp.10539). , United States Of America

Keskin, Serkan Et Al. "The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer," 2011 ASCO Annual Meeting, United States Of America, 2011

Keskin, Serkan Et Al. "The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer." 2011 ASCO Annual Meeting , United States Of America, pp.10539, 2011

Keskin, S. Et Al. (2011) . "The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer." 2011 ASCO Annual Meeting , United States Of America, p.10539.

@conferencepaper{conferencepaper, author={Serkan Keskin Et Al. }, title={The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer}, congress name={2011 ASCO Annual Meeting}, city={}, country={United States Of America}, year={2011}, pages={10539} }